The study hypothesis was that broad changes would be observed after treatment with reelin and (2 R,6 R)-HNK in proteins and signaling pathways previously implicated in the pathophysiology of TRD and in antidepressant response to ketamine, including glutamatergic synaptic signaling and inflammatory responses. The gene discussed is RELN; the disease is treatment resistant depression.